Please find all related articles below.
On 5 May 2015, Nessa Childers MEP (S&D, Ireland) will host an event co-organised by EPHA together with the Health Workers for All (HW4All) project and the European Federation of Public Service Unions (EPSU). This policy seminar, at the European Parliament in Brussels, is an opportunity to discuss the principles contained in the WHO Global Code of Practice on the International Recruitment of Health Personnel in the European context.
The event, ’Mobility of Health Professionals in (...)
Whilst there is currently little indication that the Transatlantic Trade and Investment Partnership (TTIP) would have a major direct impact on the health professions and their organization, this cannot yet be excluded in the longer term.
Issues such as mutual recognition of professional qualifications in order to boost worker mobility between the EU and the USA are not centre stage in the discussions. However, since TTIP is said to be a ‘living agreement’, these issues are not (...)
The projected shortage of over 1 million health workers by 2020 represents a serious threat to health systems in Europe. Continued action on health workforce is essential across the EU as professional imbalances can lead to growing health disparities within and between countries. Europe’s health workforce policies also have a major impact on neighbouring countries and on a global scale.
The implementation of the Action Plan for the EU Health Workforce is progressing with two key (...)
The 20th congress of EPHA member the European Association of Hospital Pharmacists (EAHP) took place in Hamburg on 25-27 March 2015. This year’s focus was ’patient safety first’, and various sessions explored how hospital pharmacists can contribute to the patient journey, for example by ensuring medication reconciliation and safety and by providing expert advice on treatments and medicines.
EPHA President Peggy Maguire - also Director General of the European Institute of (...)
In December 2014, the European Commission launched the latest public consultation on the review of the Working Time Directive 2003/88/EC in the hope to make progress following the failed negotiations of the cross-sectoral social partners at the end of 2012.
The Commission’s declared goal is to consider making appropriate changes that would make the Directive more suitable for dealing with the ongoing challenges Europe’s employment sectors are subject to. The outcomes of the (...)
In recent years, antimicrobial resistance (AMR) has been identified as a major health threat. The 2014 European Antibiotic Awareness Day drew attention to the consequences arising from the overuse and misuse of antibiotics, for instance through self-medication.
The emergence of multi-drug resistant ’superbugs’ as a result is a serious threat to health throughout Europe.
European Health Ministers recently issued Council conclusions which expand the EU level discourse about (...)
Since EU accession in 2007 Romania and Bulgaria have struggled to retain qualified health professionals. Doctors and nurses in particular have been leaving in significant numbers. Given the impacts of out-migration on health system sustainability and access to healthcare, the initiative taken by a regional hospital in Southern Romania has been highlighted by the Health Workers For All project as good practice in effective cross-border cooperation.
Long-term planning and the use of (...)
28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
Last week’s statement of the European Commission’s President-elect that the competence for (...)
Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe.
28 October 2014, Brussels (...)
Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed.
Dear Head of States, Dear Prime (...)